Exploiting Multicomponent Reactions to Drive the Development of Novel Antitubercular Agents: An Overview
ChemMedChem · 2026
DOI: 10.1002/cmdc.70423 ↗At a glance
Übersichtsarbeit in ChemMedChem, 2026. Written by Diogo Nunes and 3 co-authors. Institution: Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal. Major MEDLINE topics: Antitubercular Agents, Mycobacterium tuberculosis, Drug Discovery, Small Molecule Libraries. 140 references. The full text is freely available in PubMed Central. Funded by: Fundação para a Ciência e a Tecnologia.
Abstract (original language)
Tuberculosis (TB) remains a global epidemic, and Mycobacterium tuberculosis (Mtb), its etiological agent, continues to be the deadliest single infectious agent worldwide. Our inability to eradicate TB is strongly related to Mtb's ability to alternate between an active and latent disease state, and a lack of pharmacological agents that effectively target the heterogeneity of TB, which leads downstream to the emergence of drug resistance. The ongoing quest to discover novel effective chemical agents to improve anti‐TB regimens remains a significant challenge. Multicomponent reactions (MCRs) have been shown to generate highly diverse chemical libraries in a time‐ and cost‐efficient, sustainable manner, and thus have emerged as powerful tools to accelerate drug discovery and development. This review provides an overview of the chemical libraries of anti‐TB agents developed by MCRs, highlighting the contributions of MCRs to advance anti‐TB drug discovery through a medicinal chemistry approach.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal.
ORCID profiles: Diogo Nunes, Rui Moreira, Maria de Jesus Perry, Francisca Lopes
Funding
- Fundação para a Ciência e a Tecnologia
Cite
APA
Nunes, D., Moreira, R., Perry, M. J., & Lopes, F. (2026). Exploiting Multicomponent Reactions to Drive the Development of Novel Antitubercular Agents: An Overview. ChemMedChem. https://doi.org/10.1002/cmdc.70423
Vancouver
Nunes D, Moreira R, Perry MJ, Lopes F. Exploiting Multicomponent Reactions to Drive the Development of Novel Antitubercular Agents: An Overview. ChemMedChem. 2026. doi:10.1002/cmdc.70423
BibTeX
@article{Nunes2026,
author = {Nunes, Diogo and Moreira, Rui and Perry, Maria de Jesus and Lopes, Francisca},
title = {Exploiting Multicomponent Reactions to Drive the Development of Novel Antitubercular Agents: An Overview},
journal = {ChemMedChem},
year = {2026},
doi = {10.1002/cmdc.70423}
}
EUVIMED